 The third of the original AO/ASIF partner companies, Mathys, sold its osteosynthesis department to Synthes-Stratec in 2004, although the firm's German division was divested to satisfy competition authorities.The company subsequently dropped the "-Stratec" suffix to become simply Synthes.The company's shares were added to the benchmark Swiss Market Index for the first time in September 2004.